Aveanna Healthcare (AVAH) Expected to Post Earnings on Thursday

Aveanna Healthcare (NASDAQ:AVAH) will likely be announcing its Q2 2026 results before the market opens on Thursday, August 13th. Analysts expect the company to announce earnings of $0.1683 per share and revenue of $638.6090 million for the quarter. Interested persons may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, August 13, 2026 at 10:00 AM ET.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The firm had revenue of $647.91 million during the quarter, compared to the consensus estimate of $613.22 million. The company’s revenue was up 15.9% compared to the same quarter last year. On average, analysts expect Aveanna Healthcare to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Aveanna Healthcare Price Performance

Aveanna Healthcare stock opened at $8.95 on Wednesday. Aveanna Healthcare has a 12-month low of $5.93 and a 12-month high of $10.32. The stock has a market capitalization of $1.95 billion, a P/E ratio of 7.58, a P/E/G ratio of 0.94 and a beta of 1.90. The firm’s 50-day moving average is $8.72 and its two-hundred day moving average is $7.71. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Barclays upped their price objective on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Truist Financial lifted their target price on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a research note on Tuesday, July 14th. Weiss Ratings reissued a “hold (c+)” rating on shares of Aveanna Healthcare in a research note on Thursday, July 2nd. Royal Bank Of Canada upgraded Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective on the stock in a report on Wednesday, June 3rd. Finally, Stephens raised Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and lifted their price objective for the company from $10.00 to $11.00 in a research report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $10.78.

Insider Transactions at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $8.01, for a total transaction of $19,376,470.35. Following the transaction, the insider directly owned 10,112,123 shares of the company’s stock, valued at $80,998,105.23. The trade was a 19.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Paul R. Vigano sold 3,000,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total transaction of $24,030,000.00. Following the sale, the insider owned 190,130 shares of the company’s stock, valued at approximately $1,522,941.30. This represents a 94.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 31,305,664 shares of company stock worth $215,555,910 over the last 90 days. Company insiders own 5.30% of the company’s stock.

Hedge Funds Weigh In On Aveanna Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. Quantbot Technologies LP acquired a new stake in Aveanna Healthcare in the 2nd quarter valued at $43,000. Oxford Asset Management LLP acquired a new position in shares of Aveanna Healthcare during the second quarter worth about $64,000. Bayesian Capital Management LP acquired a new position in shares of Aveanna Healthcare during the second quarter worth about $85,000. Jain Global LLC purchased a new stake in shares of Aveanna Healthcare in the fourth quarter worth about $102,000. Finally, Invesco Ltd. boosted its position in shares of Aveanna Healthcare by 31.1% in the second quarter. Invesco Ltd. now owns 20,006 shares of the company’s stock worth $105,000 after buying an additional 4,742 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.